Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Bibliographic Details
Main Authors: Laween Uthman, Anna Homayr, Rio P. Juni, Eva L. Spin, Raphaela Kerindongo, Marleen Boomsma, Markus W. Hollmann, Benedikt Preckel, Pieter Koolwijk, Victor W.M. van Hinsbergh, Coert J. Zuurbier, Martin Albrecht, Nina C. Weber
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2019-11-01
Series:Cellular Physiology and Biochemistry
Online Access:https://www.cellphysiolbiochem.com/Articles/000178/

Internet

https://www.cellphysiolbiochem.com/Articles/000178/

Similar Items